These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 34069541)
1. Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification. Korneyenkov MA; Zamyatnin AA Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34069541 [TBL] [Abstract][Full Text] [Related]
2. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Kwon I; Schaffer DV Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830 [TBL] [Abstract][Full Text] [Related]
4. AAV Engineering for Improving Tropism to the Central Nervous System. Ghauri MS; Ou L Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829465 [TBL] [Abstract][Full Text] [Related]
5. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy. Yang L; Li J; Xiao X Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025 [TBL] [Abstract][Full Text] [Related]
6. AAV vectors: The Rubik's cube of human gene therapy. Pupo A; Fernández A; Low SH; François A; Suárez-Amarán L; Samulski RJ Mol Ther; 2022 Dec; 30(12):3515-3541. PubMed ID: 36203359 [TBL] [Abstract][Full Text] [Related]
7. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes. Dane AP; Wowro SJ; Cunningham SC; Alexander IE Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565 [TBL] [Abstract][Full Text] [Related]
9. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Grimm D; Kay MA Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018 [TBL] [Abstract][Full Text] [Related]
10. Programmable Assembly of Adeno-Associated Virus-Antibody Composites for Receptor-Mediated Gene Delivery. Zdechlik AC; He Y; Aird EJ; Gordon WR; Schmidt D Bioconjug Chem; 2020 Apr; 31(4):1093-1106. PubMed ID: 31809024 [TBL] [Abstract][Full Text] [Related]
13. Codon-Optimization of Wild-Type Adeno-Associated Virus Capsid Sequences Enhances DNA Family Shuffling while Conserving Functionality. Cabanes-Creus M; Ginn SL; Amaya AK; Liao SHY; Westhaus A; Hallwirth CV; Wilmott P; Ward J; Dilworth KL; Santilli G; Rybicki A; Nakai H; Thrasher AJ; Filip AC; Alexander IE; Lisowski L Mol Ther Methods Clin Dev; 2019 Mar; 12():71-84. PubMed ID: 30534580 [TBL] [Abstract][Full Text] [Related]
14. Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging. Drouin LM; Lins B; Janssen M; Bennett A; Chipman P; McKenna R; Chen W; Muzyczka N; Cardone G; Baker TS; Agbandje-McKenna M J Virol; 2016 Oct; 90(19):8542-51. PubMed ID: 27440903 [TBL] [Abstract][Full Text] [Related]